{"transactions":[{"id":918213,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-05T16:30:19.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price on the initial filings was incorrectly stated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option vest on February 2, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":204000,"derivative":{"exercise_price":1.96,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001910985-26-000006","document":"form4a-02052026_040214.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000191098526000006/form4a-02052026_040214.xml","form_type":"4/A","original_submission_date":"2026-02-04"}},{"id":920168,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-04T17:50:06.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":136000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of February 2, 2027, February 2, 2028, February 2, 2029 and February 2, 2030, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of February 2, 2027, February 2, 2028, February 2, 2029 and February 2, 2030, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":136000,"derivative":{"underlying":"Common Shares","underlying_shares":136000},"source":{"system":"sec-edgar","filing":"0001910985-26-000005","document":"form4-02042026_050203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000191098526000005/form4-02042026_050203.xml","form_type":"4"}},{"id":920167,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-04T17:50:06.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on February 2, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":204000,"derivative":{"exercise_price":1.97,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001910985-26-000005","document":"form4-02042026_050203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000191098526000005/form4-02042026_050203.xml","form_type":"4"}},{"id":929376,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-28T18:30:12.000Z","date":"2026-01-26","kind":"exercise","planned":false,"acquired":false,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One-fourth (1/4th) of the shares subject to the RSU award vested or will vest on each of January 26, 2026, January 26, 2027, January 26, 2028 and January 26, 2029, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"One-fourth (1/4th) of the shares subject to the RSU award vested or will vest on each of January 26, 2026, January 26, 2027, January 26, 2028 and January 26, 2029, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":60300,"derivative":{"underlying":"Common Shares","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001910985-26-000003","document":"form4-01282026_060109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000191098526000003/form4-01282026_060109.xml","form_type":"4"}},{"id":929375,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-28T18:30:12.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"50% of the option will vest on June 12, 2026 and 50% will vest on December 12, 2026, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":100000,"derivative":{"exercise_price":1.74,"expiration_date":"2034-05-06","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001910985-26-000003","document":"form4-01282026_060109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000191098526000003/form4-01282026_060109.xml","form_type":"4"}},{"id":929374,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-01-28T18:30:12.000Z","date":"2026-01-26","kind":"sale","planned":false,"acquired":false,"shares":12245,"price":1.93,"value":23632.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of PSUs or restricted stock unit (\"RSU\") awards only, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":113181,"source":{"system":"sec-edgar","filing":"0001910985-26-000003","document":"form4-01282026_060109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000191098526000003/form4-01282026_060109.xml","form_type":"4"}},{"id":929373,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-01-28T18:30:12.000Z","date":"2026-01-26","kind":"exercise","planned":false,"acquired":true,"shares":20100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each RSU represents a contingent right to receive one common share."}],"balance_after":125426,"source":{"system":"sec-edgar","filing":"0001910985-26-000003","document":"form4-01282026_060109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000191098526000003/form4-01282026_060109.xml","form_type":"4"}},{"id":929372,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-01-28T18:30:12.000Z","date":"2025-12-15","kind":"sale","planned":false,"acquired":false,"shares":58007,"price":2.32,"value":134576.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of PSUs or restricted stock unit (\"RSU\") awards only, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":105326,"source":{"system":"sec-edgar","filing":"0001910985-26-000003","document":"form4-01282026_060109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000191098526000003/form4-01282026_060109.xml","form_type":"4"}},{"id":929371,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-01-28T18:30:12.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a performance stock unit (\"PSU\") award that vested upon the certification by the Compensation Committee of the Board of Directors of the Issuer that the U.S. Food and Drug Administration has provided a New Drug Application Approval Letter granting approval of Cardamyst (etripamil)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each PSU represents a contingent right to receive one common share."}],"balance_after":163333,"source":{"system":"sec-edgar","filing":"0001910985-26-000003","document":"form4-01282026_060109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000191098526000003/form4-01282026_060109.xml","form_type":"4"}},{"id":1087698,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Series B Common Warrants (right to buy)","published_at":"2025-07-15T16:15:21.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":53333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 53,333 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 53,333 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":53333,"derivative":{"exercise_price":1.875,"expiration_date":"2030-07-11","underlying":"Common Shares","underlying_shares":53333},"source":{"system":"sec-edgar","filing":"0001415889-25-019773","document":"form4-07152025_040715.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000141588925019773/form4-07152025_040715.xml","form_type":"4"}},{"id":1087697,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Series A Common Warrants (right to buy)","published_at":"2025-07-15T16:15:21.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":53333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 53,333 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 53,333 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":53333,"derivative":{"exercise_price":1.5,"expiration_date":"2026-07-11","underlying":"Common Shares","underlying_shares":53333},"source":{"system":"sec-edgar","filing":"0001415889-25-019773","document":"form4-07152025_040715.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000141588925019773/form4-07152025_040715.xml","form_type":"4"}},{"id":1087696,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2025-07-15T16:15:21.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":53333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 53,333 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 53,333 shares of common stock."}],"balance_after":63333,"source":{"system":"sec-edgar","filing":"0001415889-25-019773","document":"form4-07152025_040715.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000141588925019773/form4-07152025_040715.xml","form_type":"4"}},{"id":1292227,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-01-29T16:15:10.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":80400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of Jaunary 27, 2026, Jaunary 27, 2027, Jaunary 27, 2028 and Jaunary 27, 2029, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of Jaunary 27, 2026, Jaunary 27, 2027, Jaunary 27, 2028 and Jaunary 27, 2029, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":80400,"derivative":{"underlying":"Common Shares","underlying_shares":80400},"source":{"system":"sec-edgar","filing":"0001415889-25-002266","document":"form4-01292025_040106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000141588925002266/form4-01292025_040106.xml","form_type":"4"}},{"id":1292226,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-29T16:15:10.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":120600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on Jaunary 27, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":120600,"derivative":{"exercise_price":2.02,"expiration_date":"2035-01-27","underlying":"Common Shares","underlying_shares":120600},"source":{"system":"sec-edgar","filing":"0001415889-25-002266","document":"form4-01292025_040106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000141588925002266/form4-01292025_040106.xml","form_type":"4"}},{"id":2009092,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-17T16:50:18.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on February 16, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":185000,"derivative":{"exercise_price":3.59,"expiration_date":"2033-02-16","underlying":"Common Shares","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001209191-23-010700","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000120919123010700/doc4.xml","form_type":"4"}},{"id":2097086,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2022-12-05T16:48:13.000Z","date":"2022-12-05","kind":"purchase","acquired":true,"shares":7000,"price":4.69,"value":32830.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-22-059720","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000120919122059720/doc4.xml","form_type":"4"}},{"id":2097085,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2022-12-05T16:48:13.000Z","date":"2022-12-01","kind":"purchase","acquired":true,"shares":3000,"price":4.86,"value":14580.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001209191-22-059720","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000120919122059720/doc4.xml","form_type":"4"}},{"id":2389739,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-17T16:48:06.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":330000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on February 15, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":330000,"derivative":{"exercise_price":6.47,"expiration_date":"2032-02-15","underlying":"Common Shares","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001209191-22-010812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000120919122010812/doc4.xml","form_type":"4"}}]}